nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—ABCA3—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.114	0.279	CbGpPWpGaD
Imatinib—ORM1—bile—sclerosing cholangitis	0.0821	0.138	CbGeAlD
Imatinib—CA9—gall bladder—sclerosing cholangitis	0.0388	0.0654	CbGeAlD
Imatinib—DDR1—pancreas—sclerosing cholangitis	0.0317	0.0534	CbGeAlD
Imatinib—PDGFRA—gall bladder—sclerosing cholangitis	0.0311	0.0524	CbGeAlD
Imatinib—KIT—gall bladder—sclerosing cholangitis	0.0249	0.0419	CbGeAlD
Imatinib—PDGFRB—gall bladder—sclerosing cholangitis	0.0243	0.0409	CbGeAlD
Imatinib—ORM1—gall bladder—sclerosing cholangitis	0.0228	0.0384	CbGeAlD
Imatinib—DDR1—liver—sclerosing cholangitis	0.0202	0.034	CbGeAlD
Imatinib—ALB—gall bladder—sclerosing cholangitis	0.02	0.0337	CbGeAlD
Imatinib—PIP4K2C—pancreas—sclerosing cholangitis	0.0196	0.033	CbGeAlD
Imatinib—CA9—Regulation of gene expression by Hypoxia-inducible Factor—HIF1A—sclerosing cholangitis	0.019	0.0469	CbGpPWpGaD
Imatinib—CA2—gall bladder—sclerosing cholangitis	0.0147	0.0248	CbGeAlD
Imatinib—NQO2—pancreas—sclerosing cholangitis	0.0144	0.0242	CbGeAlD
Imatinib—ABL2—liver—sclerosing cholangitis	0.0132	0.0222	CbGeAlD
Imatinib—PIP4K2C—liver—sclerosing cholangitis	0.0125	0.021	CbGeAlD
Imatinib—CA3—liver—sclerosing cholangitis	0.0119	0.02	CbGeAlD
Imatinib—ABCA3—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.0119	0.0292	CbGpPWpGaD
Imatinib—KIT—pancreas—sclerosing cholangitis	0.0115	0.0193	CbGeAlD
Imatinib—PDGFRB—pancreas—sclerosing cholangitis	0.0112	0.0189	CbGeAlD
Imatinib—LCK—liver—sclerosing cholangitis	0.0111	0.0186	CbGeAlD
Imatinib—CA14—liver—sclerosing cholangitis	0.0108	0.0182	CbGeAlD
Imatinib—ABL1—CDO in myogenesis—TCF4—sclerosing cholangitis	0.0107	0.0263	CbGpPWpGaD
Imatinib—CYP3A7—liver—sclerosing cholangitis	0.0106	0.0178	CbGeAlD
Imatinib—CA1—pancreas—sclerosing cholangitis	0.0105	0.0177	CbGeAlD
Imatinib—ABL1—pancreas—sclerosing cholangitis	0.00998	0.0168	CbGeAlD
Imatinib—NQO2—liver—sclerosing cholangitis	0.00915	0.0154	CbGeAlD
Imatinib—NTRK1—p75(NTR)-mediated signaling—BCL2L11—sclerosing cholangitis	0.00913	0.0225	CbGpPWpGaD
Imatinib—PDGFRA—liver—sclerosing cholangitis	0.00912	0.0154	CbGeAlD
Imatinib—CYP3A7-CYP3A51P—liver—sclerosing cholangitis	0.00898	0.0151	CbGeAlD
Imatinib—CA9—Cellular response to hypoxia—HIF1A—sclerosing cholangitis	0.00841	0.0207	CbGpPWpGaD
Imatinib—NTRK1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00819	0.0202	CbGpPWpGaD
Imatinib—CSF1R—liver—sclerosing cholangitis	0.00803	0.0135	CbGeAlD
Imatinib—ABCB1—ABC-family proteins mediated transport—CFTR—sclerosing cholangitis	0.00752	0.0185	CbGpPWpGaD
Imatinib—SLC47A1—liver—sclerosing cholangitis	0.00734	0.0124	CbGeAlD
Imatinib—KIT—liver—sclerosing cholangitis	0.00729	0.0123	CbGeAlD
Imatinib—PDGFRB—liver—sclerosing cholangitis	0.00712	0.012	CbGeAlD
Imatinib—CA2—pancreas—sclerosing cholangitis	0.00679	0.0114	CbGeAlD
Imatinib—ABL1—ErbB Signaling Pathway—BCL2L11—sclerosing cholangitis	0.00676	0.0166	CbGpPWpGaD
Imatinib—ORM1—liver—sclerosing cholangitis	0.00668	0.0113	CbGeAlD
Imatinib—CA1—liver—sclerosing cholangitis	0.00667	0.0112	CbGeAlD
Imatinib—NTRK1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00641	0.0158	CbGpPWpGaD
Imatinib—ABL1—liver—sclerosing cholangitis	0.00635	0.0107	CbGeAlD
Imatinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.0063	0.0155	CbGpPWpGaD
Imatinib—PDGFRA—Angiogenesis—HIF1A—sclerosing cholangitis	0.00627	0.0154	CbGpPWpGaD
Imatinib—CYP3A4—Farnesoid X Receptor  Pathway—ABCB4—sclerosing cholangitis	0.00618	0.0152	CbGpPWpGaD
Imatinib—SLC22A1—liver—sclerosing cholangitis	0.00612	0.0103	CbGeAlD
Imatinib—PTGS1—Eicosanoid Synthesis—GGT1—sclerosing cholangitis	0.00606	0.0149	CbGpPWpGaD
Imatinib—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00588	0.0145	CbGpPWpGaD
Imatinib—ALB—liver—sclerosing cholangitis	0.00586	0.00987	CbGeAlD
Imatinib—CYP3A5—pancreas—sclerosing cholangitis	0.00584	0.00984	CbGeAlD
Imatinib—CYP3A5—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00545	0.0134	CbGpPWpGaD
Imatinib—NTRK1—BDNF signaling pathway—BCL2L11—sclerosing cholangitis	0.00507	0.0125	CbGpPWpGaD
Imatinib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00503	0.0124	CbGpPWpGaD
Imatinib—ABL1—p73 transcription factor network—BCL2L11—sclerosing cholangitis	0.00499	0.0123	CbGpPWpGaD
Imatinib—CYP2C19—liver—sclerosing cholangitis	0.00472	0.00794	CbGeAlD
Imatinib—NTRK1—BDNF signaling pathway—ALPL—sclerosing cholangitis	0.00447	0.011	CbGpPWpGaD
Imatinib—PDGFRA—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00445	0.0109	CbGpPWpGaD
Imatinib—SLC47A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00439	0.0108	CbGpPWpGaD
Imatinib—CA2—liver—sclerosing cholangitis	0.00432	0.00728	CbGeAlD
Imatinib—ABCG2—liver—sclerosing cholangitis	0.004	0.00674	CbGeAlD
Imatinib—ABL1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.0039	0.00961	CbGpPWpGaD
Imatinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB4—sclerosing cholangitis	0.00388	0.00955	CbGpPWpGaD
Imatinib—CA9—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00387	0.00952	CbGpPWpGaD
Imatinib—ABL1—DNA Damage Response (only ATM dependent)—BCL2L11—sclerosing cholangitis	0.00386	0.00949	CbGpPWpGaD
Imatinib—CYP1A2—liver—sclerosing cholangitis	0.00385	0.00649	CbGeAlD
Imatinib—CYP3A5—liver—sclerosing cholangitis	0.00372	0.00626	CbGeAlD
Imatinib—CYP2C9—liver—sclerosing cholangitis	0.00366	0.00616	CbGeAlD
Imatinib—CA9—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00352	0.00866	CbGpPWpGaD
Imatinib—PTGS1—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00337	0.0083	CbGpPWpGaD
Imatinib—CYP1A2—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00328	0.00808	CbGpPWpGaD
Imatinib—ABL2—Developmental Biology—TCF4—sclerosing cholangitis	0.00313	0.00771	CbGpPWpGaD
Imatinib—ABCB1—pancreas—sclerosing cholangitis	0.0031	0.00523	CbGeAlD
Imatinib—CA3—Metabolism—ABCB4—sclerosing cholangitis	0.00308	0.00758	CbGpPWpGaD
Imatinib—NTRK1—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00293	0.00721	CbGpPWpGaD
Imatinib—CYP3A4—liver—sclerosing cholangitis	0.00279	0.0047	CbGeAlD
Imatinib—PDGFRA—ATF-2 transcription factor network—NOS2—sclerosing cholangitis	0.00278	0.00684	CbGpPWpGaD
Imatinib—CYP2D6—liver—sclerosing cholangitis	0.00274	0.00462	CbGeAlD
Imatinib—CYP3A4—Aflatoxin activation and detoxification—GGT1—sclerosing cholangitis	0.00253	0.00624	CbGpPWpGaD
Imatinib—LCK—Notch Signaling Pathway—HIF1A—sclerosing cholangitis	0.00215	0.00529	CbGpPWpGaD
Imatinib—KIT—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00214	0.00528	CbGpPWpGaD
Imatinib—PTGS1—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00214	0.00528	CbGpPWpGaD
Imatinib—PDGFRA—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00203	0.005	CbGpPWpGaD
Imatinib—CA14—Metabolism—ABCB4—sclerosing cholangitis	0.00198	0.00488	CbGpPWpGaD
Imatinib—LCK—IL12-mediated signaling events—NOS2—sclerosing cholangitis	0.00198	0.00488	CbGpPWpGaD
Imatinib—ABCB1—liver—sclerosing cholangitis	0.00197	0.00332	CbGeAlD
Imatinib—ABCG2—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00195	0.00481	CbGpPWpGaD
Imatinib—CYP2C19—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00194	0.00478	CbGpPWpGaD
Imatinib—CA6—Metabolism—ABCB4—sclerosing cholangitis	0.00193	0.00476	CbGpPWpGaD
Imatinib—PDGFRB—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00183	0.0045	CbGpPWpGaD
Imatinib—CA7—Metabolism—ABCB4—sclerosing cholangitis	0.0018	0.00444	CbGpPWpGaD
Imatinib—ABCG2—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.00178	0.00438	CbGpPWpGaD
Imatinib—CYP2C9—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00177	0.00436	CbGpPWpGaD
Imatinib—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—sclerosing cholangitis	0.00168	0.00415	CbGpPWpGaD
Imatinib—CA12—Metabolism—ABCB4—sclerosing cholangitis	0.00167	0.00412	CbGpPWpGaD
Imatinib—CYP1A2—Arachidonic acid metabolism—GGT1—sclerosing cholangitis	0.00151	0.00373	CbGpPWpGaD
Imatinib—NTRK1—Circadian rythm related genes—NOS2—sclerosing cholangitis	0.0015	0.0037	CbGpPWpGaD
Imatinib—LCK—Signaling by NGF—BCL2L11—sclerosing cholangitis	0.00147	0.00361	CbGpPWpGaD
Imatinib—CA3—Metabolism—GOT2—sclerosing cholangitis	0.00146	0.0036	CbGpPWpGaD
Imatinib—ABCG2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00145	0.00358	CbGpPWpGaD
Imatinib—SLC22A2—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00144	0.00354	CbGpPWpGaD
Imatinib—ALB—Selenium Micronutrient Network—GGT1—sclerosing cholangitis	0.00138	0.00339	CbGpPWpGaD
Imatinib—SLC22A1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.00134	0.0033	CbGpPWpGaD
Imatinib—CYP3A7—Biological oxidations—GGT1—sclerosing cholangitis	0.00129	0.00319	CbGpPWpGaD
Imatinib—CA2—Metabolism—ABCB4—sclerosing cholangitis	0.00128	0.00315	CbGpPWpGaD
Imatinib—CA9—Cellular responses to stress—HIF1A—sclerosing cholangitis	0.00128	0.00314	CbGpPWpGaD
Imatinib—CA3—Metabolism—GOT1—sclerosing cholangitis	0.00126	0.00311	CbGpPWpGaD
Imatinib—CA3—Metabolism—GGT1—sclerosing cholangitis	0.00126	0.00311	CbGpPWpGaD
Imatinib—PTGS1—Biological oxidations—GGT1—sclerosing cholangitis	0.00125	0.00309	CbGpPWpGaD
Imatinib—CA1—Metabolism—ABCB4—sclerosing cholangitis	0.00123	0.00302	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.00117	0.00289	CbGpPWpGaD
Imatinib—ABL1—Developmental Biology—TCF4—sclerosing cholangitis	0.00111	0.00272	CbGpPWpGaD
Imatinib—CA9—Metabolism—ABCB4—sclerosing cholangitis	0.00108	0.00265	CbGpPWpGaD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—HIF1A—sclerosing cholangitis	0.00106	0.0026	CbGpPWpGaD
Imatinib—CYP1A2—Phase II conjugation—GGT1—sclerosing cholangitis	0.000963	0.00237	CbGpPWpGaD
Imatinib—ABCB1—HIF-1-alpha transcription factor network—NOS2—sclerosing cholangitis	0.000961	0.00237	CbGpPWpGaD
Imatinib—CA14—Metabolism—GOT2—sclerosing cholangitis	0.000942	0.00232	CbGpPWpGaD
Imatinib—CYP3A5—Biological oxidations—GGT1—sclerosing cholangitis	0.000935	0.0023	CbGpPWpGaD
Imatinib—CA6—Metabolism—GOT2—sclerosing cholangitis	0.000918	0.00226	CbGpPWpGaD
Imatinib—ALB—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000897	0.00221	CbGpPWpGaD
Imatinib—CA7—Metabolism—GOT2—sclerosing cholangitis	0.000857	0.00211	CbGpPWpGaD
Imatinib—CA14—Metabolism—GGT1—sclerosing cholangitis	0.000813	0.002	CbGpPWpGaD
Imatinib—CA14—Metabolism—GOT1—sclerosing cholangitis	0.000813	0.002	CbGpPWpGaD
Imatinib—CA12—Metabolism—GOT2—sclerosing cholangitis	0.000794	0.00196	CbGpPWpGaD
Imatinib—CA6—Metabolism—GGT1—sclerosing cholangitis	0.000793	0.00195	CbGpPWpGaD
Imatinib—CA6—Metabolism—GOT1—sclerosing cholangitis	0.000793	0.00195	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—CFTR—sclerosing cholangitis	0.000786	0.00194	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000754	0.00186	CbGpPWpGaD
Imatinib—CA7—Metabolism—GGT1—sclerosing cholangitis	0.00074	0.00182	CbGpPWpGaD
Imatinib—CA7—Metabolism—GOT1—sclerosing cholangitis	0.00074	0.00182	CbGpPWpGaD
Imatinib—CYP2C19—Biological oxidations—GGT1—sclerosing cholangitis	0.000723	0.00178	CbGpPWpGaD
Imatinib—CA12—Metabolism—GGT1—sclerosing cholangitis	0.000686	0.00169	CbGpPWpGaD
Imatinib—CA12—Metabolism—GOT1—sclerosing cholangitis	0.000686	0.00169	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000677	0.00167	CbGpPWpGaD
Imatinib—CYP2D6—Biological oxidations—GGT1—sclerosing cholangitis	0.000665	0.00164	CbGpPWpGaD
Imatinib—CYP2C9—Biological oxidations—GGT1—sclerosing cholangitis	0.000659	0.00162	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000629	0.00155	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000617	0.00152	CbGpPWpGaD
Imatinib—CA2—Metabolism—GOT2—sclerosing cholangitis	0.000607	0.0015	CbGpPWpGaD
Imatinib—CA1—Metabolism—GOT2—sclerosing cholangitis	0.000582	0.00143	CbGpPWpGaD
Imatinib—CYP1A2—Biological oxidations—GGT1—sclerosing cholangitis	0.000563	0.00139	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ABCB4—sclerosing cholangitis	0.000544	0.00134	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ABCB4—sclerosing cholangitis	0.00054	0.00133	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ABCB4—sclerosing cholangitis	0.000539	0.00133	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ABCB4—sclerosing cholangitis	0.000528	0.0013	CbGpPWpGaD
Imatinib—CA2—Metabolism—GGT1—sclerosing cholangitis	0.000524	0.00129	CbGpPWpGaD
Imatinib—CA2—Metabolism—GOT1—sclerosing cholangitis	0.000524	0.00129	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ABCB4—sclerosing cholangitis	0.000523	0.00129	CbGpPWpGaD
Imatinib—CA9—Metabolism—GOT2—sclerosing cholangitis	0.000512	0.00126	CbGpPWpGaD
Imatinib—CA1—Metabolism—GGT1—sclerosing cholangitis	0.000503	0.00124	CbGpPWpGaD
Imatinib—CA1—Metabolism—GOT1—sclerosing cholangitis	0.000503	0.00124	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ABCB4—sclerosing cholangitis	0.000502	0.00124	CbGpPWpGaD
Imatinib—PTGS1—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000482	0.00119	CbGpPWpGaD
Imatinib—KIT—Disease—GOT2—sclerosing cholangitis	0.000466	0.00115	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000461	0.00113	CbGpPWpGaD
Imatinib—CA9—Metabolism—GGT1—sclerosing cholangitis	0.000442	0.00109	CbGpPWpGaD
Imatinib—CA9—Metabolism—GOT1—sclerosing cholangitis	0.000442	0.00109	CbGpPWpGaD
Imatinib—PDGFRA—Disease—GOT2—sclerosing cholangitis	0.000441	0.00109	CbGpPWpGaD
Imatinib—ABL1—Hemostasis—NOS2—sclerosing cholangitis	0.000437	0.00108	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000436	0.00107	CbGpPWpGaD
Imatinib—CYP3A4—Biological oxidations—GGT1—sclerosing cholangitis	0.000435	0.00107	CbGpPWpGaD
Imatinib—KIT—Disease—GOT1—sclerosing cholangitis	0.000402	0.00099	CbGpPWpGaD
Imatinib—PDGFRB—Disease—GOT2—sclerosing cholangitis	0.000397	0.000978	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000393	0.000967	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ABCB4—sclerosing cholangitis	0.00039	0.00096	CbGpPWpGaD
Imatinib—PDGFRA—Disease—GOT1—sclerosing cholangitis	0.000381	0.000937	CbGpPWpGaD
Imatinib—LCK—Hemostasis—NOS2—sclerosing cholangitis	0.00036	0.000886	CbGpPWpGaD
Imatinib—PDGFRB—Disease—GOT1—sclerosing cholangitis	0.000343	0.000844	CbGpPWpGaD
Imatinib—ALB—Metabolism—ABCB4—sclerosing cholangitis	0.000336	0.000827	CbGpPWpGaD
Imatinib—LCK—Disease—GOT2—sclerosing cholangitis	0.000319	0.000785	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—BCL2L11—sclerosing cholangitis	0.000315	0.000776	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000309	0.000762	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ABCB4—sclerosing cholangitis	0.000302	0.000743	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ABCB4—sclerosing cholangitis	0.000294	0.000725	CbGpPWpGaD
Imatinib—KIT—Disease—HIF1A—sclerosing cholangitis	0.00028	0.000689	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000278	0.000684	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ABCB4—sclerosing cholangitis	0.000277	0.000683	CbGpPWpGaD
Imatinib—LCK—Disease—GOT1—sclerosing cholangitis	0.000275	0.000678	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ABCB4—sclerosing cholangitis	0.000275	0.000677	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000267	0.000658	CbGpPWpGaD
Imatinib—PDGFRA—Disease—HIF1A—sclerosing cholangitis	0.000265	0.000652	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GOT2—sclerosing cholangitis	0.000259	0.000637	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GOT2—sclerosing cholangitis	0.000256	0.000631	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GOT2—sclerosing cholangitis	0.000256	0.00063	CbGpPWpGaD
Imatinib—KIT—Disease—NOS2—sclerosing cholangitis	0.000254	0.000627	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000253	0.000623	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GOT2—sclerosing cholangitis	0.000249	0.000612	CbGpPWpGaD
Imatinib—PDGFRA—Disease—NOS2—sclerosing cholangitis	0.000241	0.000593	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT2—sclerosing cholangitis	0.000239	0.000587	CbGpPWpGaD
Imatinib—PDGFRB—Disease—HIF1A—sclerosing cholangitis	0.000239	0.000587	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ABCB4—sclerosing cholangitis	0.000235	0.000579	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GGT1—sclerosing cholangitis	0.000223	0.00055	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—GOT1—sclerosing cholangitis	0.000223	0.00055	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GGT1—sclerosing cholangitis	0.000221	0.000545	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—GOT1—sclerosing cholangitis	0.000221	0.000545	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GOT1—sclerosing cholangitis	0.000221	0.000544	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—GGT1—sclerosing cholangitis	0.000221	0.000544	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS2—sclerosing cholangitis	0.000217	0.000534	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—sclerosing cholangitis	0.000216	0.000533	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS2—sclerosing cholangitis	0.000215	0.000529	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GGT1—sclerosing cholangitis	0.000215	0.000528	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—GOT1—sclerosing cholangitis	0.000215	0.000528	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GOT1—sclerosing cholangitis	0.000206	0.000507	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—GGT1—sclerosing cholangitis	0.000206	0.000507	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000196	0.000482	CbGpPWpGaD
Imatinib—LCK—Disease—HIF1A—sclerosing cholangitis	0.000191	0.000471	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000185	0.000457	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT2—sclerosing cholangitis	0.000185	0.000456	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ABCB4—sclerosing cholangitis	0.000181	0.000447	CbGpPWpGaD
Imatinib—LCK—Disease—NOS2—sclerosing cholangitis	0.000174	0.000429	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000167	0.000411	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GGT1—sclerosing cholangitis	0.00016	0.000394	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—GOT1—sclerosing cholangitis	0.00016	0.000394	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT2—sclerosing cholangitis	0.00016	0.000393	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT2—sclerosing cholangitis	0.000143	0.000353	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT2—sclerosing cholangitis	0.00014	0.000344	CbGpPWpGaD
Imatinib—ALB—Metabolism—GGT1—sclerosing cholangitis	0.000138	0.000339	CbGpPWpGaD
Imatinib—ALB—Metabolism—GOT1—sclerosing cholangitis	0.000138	0.000339	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—HIF1A—sclerosing cholangitis	0.000134	0.00033	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT2—sclerosing cholangitis	0.000132	0.000324	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT2—sclerosing cholangitis	0.000131	0.000322	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GGT1—sclerosing cholangitis	0.000124	0.000305	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—GOT1—sclerosing cholangitis	0.000124	0.000305	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GGT1—sclerosing cholangitis	0.000121	0.000297	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—GOT1—sclerosing cholangitis	0.000121	0.000297	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GOT1—sclerosing cholangitis	0.000114	0.00028	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—GGT1—sclerosing cholangitis	0.000114	0.00028	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GOT1—sclerosing cholangitis	0.000113	0.000278	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—GGT1—sclerosing cholangitis	0.000113	0.000278	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT2—sclerosing cholangitis	0.000112	0.000275	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GGT1—sclerosing cholangitis	9.64e-05	0.000237	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—GOT1—sclerosing cholangitis	9.64e-05	0.000237	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT2—sclerosing cholangitis	8.62e-05	0.000212	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GOT1—sclerosing cholangitis	7.44e-05	0.000183	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GGT1—sclerosing cholangitis	7.44e-05	0.000183	CbGpPWpGaD
